Memorial Sloan - Kettering Cancer Center logo

Memorial Sloan - Kettering Cancer Center

North America, New York, United States, New York

Description

Memorial Sloan - Kettering Cancer Center develops health-related apps and educational programs for mobile platforms.

Investor Profile

Memorial Sloan - Kettering Cancer Center has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (33%)
  • Series Unknown (17%)
  • Series B (17%)
  • Series A (17%)
  • Series D (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Biopharma
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Health Diagnostics
  • Artificial Intelligence (Ai)
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Memorial Sloan - Kettering Cancer Center frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 3
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Casdin Capital
North America, New York, United States, New York
Co-Investments: 2
Taiho Ventures
North America, California, United States, California City
Co-Investments: 2
The Column Group
North America, California, United States, San Francisco
Co-Investments: 2
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 2
KI
North America, New York, United States, New York
Co-Investments: 2
Invus
North America, New York, United States, New York
Co-Investments: 2
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 2

What are some of recent deals done by Memorial Sloan - Kettering Cancer Center?

Flare Therapeutics

Cambridge, Massachusetts, United States

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

BiopharmaBiotechnologyHealth CareLife Science
Series BMar 22, 2023
Amount Raised: $123,000,000
Blue Note Therapeutics

San Francisco, California, United States

Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise.

Health CareHealth DiagnosticsMedicalTherapeutics
Series ASep 9, 2021
Amount Raised: $5,200,000
Ajax Therapeutics

Cambridge, Massachusetts, United States

Ajax Therapeutics is a biotechnology company developing therapies to target cytokine signaling pathways that drive hematologic malignancies.

BiotechnologyLife ScienceMedical
Series UnknownJun 1, 2021
Amount Raised: $40,000,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series DAug 9, 2019
Amount Raised: $55,000,000
COTA Healthcare

New York, New York, United States

Bringing clarity to cancer. Working to ensure that everyone touched by cancer has a clear path to the right care.

Artificial Intelligence (AI)BiotechnologyHealth CareLife Science
Series CFeb 21, 2018
Amount Raised: $40,000,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series CFeb 21, 2018
Amount Raised: $50,000,000